Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Gala Pharmaceutical Inc GLPH

Gala Pharmaceutical Inc is a United States-based company engaged in the hemp and cannabidiol (CBD) industry. It is focused on the development, research, and commercialization of products derived from the hemp and cannabis plant. It is focused on CBD flavored thin-film strip which is an advanced method of providing CBD for the dietary supplement. The services offered by the company are the... see more

OTCPK:GLPH - Post Discussion

Gala Pharmaceutical Inc > USOTC: GLAG
View:
Post by JAYLIN on Feb 20, 2015 12:04pm

USOTC: GLAG

GLAG has applied for MMPR, the company is made up of BOD of US: GRNH They've also added artist Paul Frank who's worth about $100mm to the board to develop a hemp based clothing line. https://finance.yahoo.com/news/gala-global-reports-significant-progress-130000220.html
Comment by JAYLIN on Feb 20, 2015 12:12pm
They're also developing CBD products in FDA lab. A lot of money behind this, since reverse merging in around June. https://finance.yahoo.com/news/gala-global-finalize-initial-hemp-130000245.html
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities